Aimmune Therapeutics Inc. (AIMT)

27.78 -0.12 (-0.43%)

IEX Real-Time Price

9:30:02 AM EST.

Nasdaq Global Select : Healthcare

Prev Close 27.9

Price Open 28.06

Volume: 5,615

Avg Volume: 323,928

Market Cap: 1.62B

P/E Ratio -8.5

52 Wk Range 18.74-42



AIMT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
57.54M
5.78M
18.43
10.04%

2018-07-13
57.16M
5.88M
10.00
10.29%

2018-06-29
57.16M
5.91M
9.34
10.34%

2018-06-15
57.18M
5.19M
9.91
9.08%




AIMT Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-14
Q1 2018
N/A
-0.66 (5)
0.00
0.00

2018-05-08
Q1 2018
N/A
-0.66 (5)
-0.92
-0.26

2018-03-21
Q4 2017
N/A
-0.70 (5)
0.00
0.00

2018-03-12
Q4 2017
N/A
-0.72 (5)
-0.81
-0.09

News

Here, Take Another Hit Of This, Then Sell Some More Aimmune (2018-08-13 21:03 SeekingAlpha)

Once again investors have smoked the strong stuff and sold Aimmune Therapeutics (AIMT) to levels that underprice its true value and potential. More patient - read thoughtful - investors should find these valuations compelling and an excellent entry point. Aimmune has fallen significantly below…

 


Statistics

Shares Outstanding: 58.48M

Top 15 Institution Percent: N/A

Price To Sales: N/A

Price To Book: 5.69

Revenue: N/A

Gross Profit: N/A

Cash: 394.46M

Debt: N/A

Return On Assets: -60.04

Return On Equity: -66.72

Profit Margin: N/A

Price History

Beta: -0.30

50-day Moving Avg: 29.04

200-day Moving Avg: 32.58

YTD Change: -25.38

5-day Change: -1.73

1-month Change: -4.16

3-month Change: -6.88

6-month Change: -25.00

1-year Change: 41.98

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Aimmune Therapeutics Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.aimmune.com

Aimmune Therapeutics Inc is engaged in the field of biotechnology. It researches and develops drug candidates for the treatment of peanut and other food allergies.